We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+0.38%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.1B
AUM Growth
-$502M
Cap. Flow
-$489M
Cap. Flow %
-4.05%
Top 10 Hldgs %
13.99%
Holding
580
New
160
Increased
90
Reduced
147
Closed
142

Top Buys

Rank Stock Value
1
CHKP icon
Check Point Software Technologies
CHKP
+$181M
2
PM icon
Philip Morris
PM
+$152M
3
AVGO icon
Broadcom
AVGO
+$140M
4
BAC icon
Bank of America
BAC
+$111M
5
D icon
Dominion Energy
D
+$109M

Top Sells

Rank Stock Value
1
AZO icon
AutoZone
AZO
+$193M
2
GE icon
GE Aerospace
GE
+$149M
3
AYI icon
Acuity Brands
AYI
+$143M
4
KEY icon
KeyCorp
KEY
+$133M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$131M

Sector Composition

Rank Sector Weight
1 Technology 20.78%
2 Industrials 13.32%
3 Healthcare 10.76%
4 Energy 9.69%
5 Consumer Discretionary 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATYR
351
aTyr Pharma
ATYR
$50.1M
$1.85M 0.02%
49,874
-449
-0.9% -$21K
ACIA
352
DELISTED
Acacia Communications Inc
ACIA
$1.81M 0.02%
+47,105
New +$1.86M
UTI icon
353
Universal Technical Institute
UTI
$1.59B
$1.8M 0.01%
614,011
+38,358
+7% +$102K
LUMO
354
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.8M 0.01%
27,529
-249
-0.9% -$17.6K
XNCR icon
355
Xencor
XNCR
$1.55B
$1.79M 0.01%
+59,590
New +$1.56M
NITE
356
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$1.77M 0.01%
123,884
+23,884
+24% +$326K
WMB icon
357
Williams Companies
WMB
$86.1B
$1.76M 0.01%
+70,665
New +$2.09M
ASND icon
358
Ascendis Pharma A/S
ASND
$16.8B
$1.75M 0.01%
26,700
-59,800
-69% -$3.36M
TKR icon
359
Timken Company
TKR
$9.03B
$1.72M 0.01%
+37,814
New +$1.82M
ACER
360
DELISTED
Acer Therapeutics Inc
ACER
$1.72M 0.01%
89,398
+14,398
+19% +$264K
ARMO
361
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
$1.7M 0.01%
+45,403
New +$1.91M
PTN
362
CALL
Palatin Technologies
PTN
$13.8M
$1.68M 0.01%
1,231
– –
OMED
363
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.65M 0.01%
517,223
-4,660
-0.9% -$12.8K
HXL icon
364
Hexcel
HXL
$7.82B
$1.63M 0.01%
25,244
-755,283
-97% -$49.7M
JILL icon
365
J. Jill
JILL
$283M
$1.61M 0.01%
86,810
-75,690
-47% -$2.42M
TOVX icon
366
CALL
Theriva Biologics
TOVX
$10.1M
$1.59M 0.01%
571
– –
GNCA
367
CALL
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.57M 0.01%
+187,500
New +$1.56M
AVYA
368
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$1.53M 0.01%
+68,228
New +$1.46M
DCPH
369
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.51M 0.01%
75,329
-25,086
-25% -$635K
FOLD
370
DELISTED
Amicus Therapeutics
FOLD
$1.5M 0.01%
+100,000
New +$1.52M
IMDZ
371
DELISTED
Immune Design Corp.
IMDZ
$1.49M 0.01%
452,516
-47,484
-9% -$168K
SYNC
372
DELISTED
Synacor, Inc.
SYNC
$1.43M 0.01%
890,536
-130,727
-13% -$265K
ZS icon
373
Zscaler
ZS
$27.3B
$1.4M 0.01%
+50,000
New +$1.46M
SGYP
374
CALL
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.37M 0.01%
750,000
– –
DHI icon
375
D.R. Horton
DHI
$42.3B
$1.37M 0.01%
+31,302
New +$1.46M
13 14
15
16 17

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q1 2018 Portfolio in Review

As of Q1 2018, Alyeska Investment Group held 580 positions worth $12.1B, down 4% from $12.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Alyeska Investment Group withdrew a net $489M in Q1 2018, closing 142 positions and reducing 147 holdings. Its most notable exit was GE Aerospace, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Alyeska Investment Group opened a new position in Philip Morris worth $145M.

  • Alyeska Investment Group's largest Q1 2018 buy was Philip Morris: 1,458,712 shares worth $145M.
  • Alyeska Investment Group added most to Check Point Software Technologies in Q1 2018, an estimated $181M increase.
  • Alyeska Investment Group's biggest Q1 2018 reduction was AutoZone, cutting an estimated $193M.
  • Alyeska Investment Group fully exited GE Aerospace in Q1 2018, selling an estimated $149M.
  • Alyeska Investment Group's ten largest holdings make up 14% of its $12.1B portfolio in Q1 2018.
  • Alyeska Investment Group opened 160 new positions and closed 142 in Q1 2018.
  • Alyeska Investment Group's portfolio value fell 4% quarter-over-quarter to $12.1B.

Based on Alyeska Investment Group's 13F filing for Q1 2018, filed 15 May 2018.